RESIDUAL SITE RADIATION THERAPY: AN OPPORTUNITY TO INCREASE SAFETY OF COMBINED MODALITY THERAPY FOR EARLY STAGE HODGKIN LYMPHOMA

被引：0
|
作者：
Straus, D. [1 ]
Cahlon, O. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P058
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [41] Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study
    Hoppe, Bradford S.
    Flampouri, Stella
    Zaiden, Robert
    Slayton, William
    Sandler, Eric
    Ozdemir, Savas
    Dang, Nam H.
    Lynch, James W.
    Li, Zuofeng
    Morris, Christopher G.
    Mendenhall, Nancy P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (05): : 1053 - 1059
  • [42] Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
    Gunther, Jillian R.
    Pinnix, Chelsea C.
    Glober, Gordon R.
    Christopherson, Kaitlin M.
    Fang, Penny
    Lee, Hun Ju
    Ahmed, Sairah
    Steiner, Raphael E.
    Nair, Ranjit
    Strati, Paolo
    Neelapu, Sattva S.
    Nastoupil, Loretta J.
    Dabaja, Bouthaina S.
    EJHAEM, 2020, 1 (01): : 272 - 276
  • [43] Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival
    Zhang, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : 500 - 500
  • [44] Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging
    David J. Iberri
    Richard T. Hoppe
    Ranjana H. Advani
    Current Treatment Options in Oncology, 2015, 16
  • [45] COMBINED MODALITY THERAPY FOR STAGE-I-II LARGE CELL LYMPHOMA
    PRESTIDGE, BR
    HORNING, SJ
    HOPPE, RT
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (03): : 633 - 639
  • [46] Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival
    Parikh, Rahul R.
    Grossbard, Michael L.
    Harrison, Louis B.
    Yahalom, Joachim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : 684 - 693
  • [47] The Case for Combined-Modality Therapy for Limited-Stage Hodgkin's Disease
    Hill-Kayser, Christine E.
    Plastaras, John P.
    Tochner, Zelig
    Glatstein, Eli
    ONCOLOGIST, 2012, 17 (08): : 1006 - 1010
  • [48] Combined modality therapy for stage I-II MALT lymphoma and mantle cell lymphoma
    McLaughlin, P
    Seymour, J
    Fuller, L
    Cabanillas, F
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 211 - 213
  • [49] COMBINED MODALITY THERAPY FOR PRIMARY CNS LYMPHOMA
    DEANGELIS, LM
    YAHALOM, J
    THALER, HT
    KHER, U
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 635 - 643
  • [50] Optimizing combined modality therapy for Hodgkin's disease
    Prosnitz, LR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01): : 1 - 2
12345